Where Ducommun Stands With Analysts

In the last three months, 4 analysts have published ratings on Ducommun DCO, offering a diverse range of perspectives from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 1 0 0 0
Last 30D 2 1 0 0 0
1M Ago 0 0 0 0 0
2M Ago 1 0 0 0 0
3M Ago 0 0 0 0 0

Analysts have recently evaluated Ducommun and provided 12-month price targets. The average target is $66.5, accompanied by a high estimate of $72.00 and a low estimate of $60.00. This current average has increased by 1.53% from the previous average price target of $65.50.

price target chart

Exploring Analyst Ratings: An In-Depth Overview

A comprehensive examination of how financial experts perceive Ducommun is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Ken Herbert RBC Capital Maintains Outperform $60.00 -
Mike Crawford B. Riley Securities Maintains Buy $72.00 -
Michael Ciarmoli Truist Securities Lowers Buy $65.00 $69.00
Michael Ciarmoli Truist Securities Raises Buy $69.00 $62.00

Key Insights:

  • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ducommun. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ducommun compared to the broader market.
  • Price Targets: Delving into movements, analysts provide estimates for the future value of Ducommun's stock. This analysis reveals shifts in analysts' expectations over time.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Ducommun's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Ducommun analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Discovering Ducommun: A Closer Look

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used primarily in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers, and manufactures large, complex contoured aerostructure components & assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers, and manufactures high-reliability electronic & electromechanical products used in worldwide technology-driven markets including aerospace and defense, industrial, medical, & other end-use markets. It generates most of its revenue from the Electronic Systems.

Ducommun: Financial Performance Dissected

Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.

Positive Revenue Trend: Examining Ducommun's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.18% as of 30 September, 2023, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.

Net Margin: Ducommun's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 1.64%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.51%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): Ducommun's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.28% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: Ducommun's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.48.

Analyst Ratings: What Are They?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!